Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
1(17%)
Results Posted
0%(0 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_4
1
17%
Ph phase_2
1
17%
Ph not_applicable
1
17%
Ph phase_1
2
33%

Phase Distribution

2

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(3)
Terminated(1)
Other(1)

Detailed Status

Completed3
unknown1
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (40.0%)
Phase 21 (20.0%)
Phase 41 (20.0%)
N/A1 (20.0%)

Trials by Status

unknown117%
recruiting117%
completed350%
terminated117%

Recent Activity

1 active trials
Showing 5 of 6
completedphase_1

Safety, Tolerability, PK & PD of AB-101 Following Oral Administration in Healthy and CHB Subjects.

NCT05960240
recruitingnot_applicable

A Prospective Study to Evaluate Peginterferon in Reducing the Incidence of HCC in CHB Patients

NCT05671315
terminatedphase_1

Safety, Tolerability, and Pharmacokinetics of AB-836 in Healthy Subjects and Subjects With Chronic HBV Infection

NCT04775797
unknownphase_2

Safety and Efficacy of Celecoxib Plus Nucleos(t)Ide Analogues on the Hepatitis B Surface Antigen of Virally Suppressed Subjects With Chronic Hepatitis B

NCT05256823
completedphase_4

PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients

NCT01373684
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05960240Phase 1

Safety, Tolerability, PK & PD of AB-101 Following Oral Administration in Healthy and CHB Subjects.

Completed
NCT05671315Not Applicable

A Prospective Study to Evaluate Peginterferon in Reducing the Incidence of HCC in CHB Patients

Recruiting
NCT04775797Phase 1

Safety, Tolerability, and Pharmacokinetics of AB-836 in Healthy Subjects and Subjects With Chronic HBV Infection

Terminated
NCT05256823Phase 2

Safety and Efficacy of Celecoxib Plus Nucleos(t)Ide Analogues on the Hepatitis B Surface Antigen of Virally Suppressed Subjects With Chronic Hepatitis B

Unknown
NCT01373684Phase 4

PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients

Completed
NCT03977987

Maternal Antiviral Treatment and Infants Immunoprophylaxis in the Prevention of Mother-to-child Transmission

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6